EUVIMEDEUVIMED entdecken
FallberichtOpen Access

A novel case of cutaneous myxoid spindle cell neoplasm with FMR1‐ALK gene fusion and CD34 / S100 co‐expression

Israel Kasago iD, Umut Aypar, Purvil Sukhadia, Chad Vanderbilt, Marc Ladanyi, Tierra Hurd, Melissa Pulitzer iD

Journal of Cutaneous Pathology · 2023

DOI: 10.1111/cup.14354 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cutaneous Pathology, 2023. Verfasst von Israel Kasago und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Skin Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH/NCI Cancer Center Support Grant P30 CA008748.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel class of superficial CD34 + and S100 + cutaneous spindle cell neoplasm harboring ALK rearrangements has recently been described. Morphologically, these neoplasms have been characterized by bland spindled cells organized in whorls and cords against myxoid stroma, eventuating in the designation “superficial ALK ‐rearranged myxoid spindle cell neoplasm.” Here, we report a 78‐year‐old male with a 3‐mm pink papule on the chest, clinically concerning for cutaneous carcinoma. Biopsy of the specimen showed a biphasic tumor with hypercellular and hypocellular zones consisting of epithelioid cells and monomorphic, bland spindled cells. The spindled cells were arranged in perineurial‐like concentric whorls and cords embedded in a myxo‐collagenous stroma. Neoplastic cells were diffusely positive for CD34, S100, and D5F3‐ALK, without SOX10 expression. Negative markers included GLUT1, EMA, factor XIIIa, desmin, actin, and SMA. ALK‐ rearrangement was identified on fluorescence in situ hybridization break‐apart assay. A corresponding novel FMR1‐ALK fusion was found by next‐generation sequencing (NGS) based RNA sequencing. Identification of this new FMR1‐ALK fusion signature adds to the spectrum of diagnostic genomic alterations in this newly described class of tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsMaleHumansAgedIn Situ Hybridization, FluorescenceBiopsyReceptor Protein-Tyrosine KinasesGene FusionBiomarkers, TumorGene RearrangementFragile X Messenger Ribonucleoprotein 1

Stichwörter der Autor:innen

CD34FMR1-ALK fusionS100kinase fusionsspindle cell neoplasms

Substanzen

Receptor Protein-Tyrosine KinasesBiomarkers, TumorFragile X Messenger Ribonucleoprotein 1FMR1 protein, human

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Israel Kasago, Melissa Pulitzer

Förderung

  • NCI NIH HHS
  • NIH/NCI Cancer Center Support Grant P30 CA008748

Zitieren

APA

Kasago, I., Aypar, U., Sukhadia, P., Vanderbilt, C., Ladanyi, M., Hurd, T., & Pulitzer, M. (2023). A novel case of cutaneous myxoid spindle cell neoplasm with FMR1‐ALK gene fusion and CD34 / S100 co‐expression. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14354

Vancouver

Kasago I, Aypar U, Sukhadia P, Vanderbilt C, Ladanyi M, Hurd T, et al. A novel case of cutaneous myxoid spindle cell neoplasm with FMR1‐ALK gene fusion and CD34 / S100 co‐expression. Journal of Cutaneous Pathology. 2023. doi:10.1111/cup.14354

BibTeX
@article{Kasago2023,
  author = {Kasago, Israel and Aypar, Umut and Sukhadia, Purvil and Vanderbilt, Chad and Ladanyi, Marc and Hurd, Tierra and Pulitzer, Melissa},
  title = {A novel case of cutaneous myxoid spindle cell neoplasm with FMR1‐ALK gene fusion and CD34 / S100 co‐expression},
  journal = {Journal of Cutaneous Pathology},
  year = {2023},
  doi = {10.1111/cup.14354}
}
Kostenlos starten →